News

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.
A 40 year old man presented with general malaise, pyrexia, and microembolic phenomena. Blood cultures were positive for α haemolytic streptococcus. A transthoracic echocardiogram showed several small ...
The Montreal Heart Institute has opened its new state-of-the-art Heart Valve Therapy Centre which will allow the Institute to ...
MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...
In TODAY.com's Expert Tip of the Day, a cardiologist explains why neglecting your "second heart" can lead to health ...
A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...
NEW YORK CITY -- Operators acknowledged the complex electrophysiological concerns around transcatheter tricuspid valve ...
Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...
One Saint Luke’s Mid-America Heart Institute patient is sharing her lifelong journey with heart disease that has left ...
Cutting-Edge Technology The devices used in the procedures were Aeson artificial hearts, which were developed by the French ...
Aortic valve repair and replacement continue to grab attention appropriate for the number of people affected, but the heart’s other three valves are finally gaining some respect as med-tech companies ...
Holston Valley Medical Center has become the first hospital in Tennessee to successfully perform the EVOQUE tricuspid valve replacement procedure, a groundbreaking, minimally invasive therapy for ...